Realta Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-388
Closed -$202K 818
2023
Q2
$202K Sell
388
-41
-10% -$22.1K 0.04% 394
2023
Q1
$247K Sell
429
-17
-4% -$9.58K 0.06% 331
2022
Q4
$246K Sell
446
-4
-0.9% -$2.12K 0.06% 347
2022
Q3
$228K Sell
450
-20
-4% -$11.2K 0.06% 336
2022
Q2
$257K Sell
470
-117
-20% -$64.4K 0.06% 299
2022
Q1
$347K Buy
587
+171
+41% +$98.2K 0.07% 276
2021
Q4
$278K Buy
416
+11
+3% +$6.87K 0.06% 329
2021
Q3
$232K Sell
405
-114
-22% -$62.6K 0.05% 351
2021
Q2
$262K Sell
519
-30
-5% -$14.2K 0.06% 316
2021
Q1
$251K Buy
549
+23
+4% +$11K 0.07% 309
2020
Q4
$245K Sell
526
-27
-5% -$12.7K 0.07% 276
2020
Q3
$244K Sell
553
-1,087
-66% -$449K 0.08% 262
2020
Q2
$594K Sell
1,640
-328
-17% -$110K 0.2% 128
2020
Q1
$558K Sell
1,968
-21
-1% -$6.62K 0.24% 115
2019
Q4
$624K Buy
1,989
+84
+4% +$25.5K 0.17% 155
2019
Q3
$555K Sell
1,905
-367
-16% -$105K 0.15% 163
2019
Q2
$666K Sell
2,272
-100
-4% -$27.5K 0.18% 138
2019
Q1
$646K Buy
+2,372
New +$590K 0.29% 104

Other funds holding TMO

Realta Investment Advisors's TMO Position: Q3 2023 in Review

Realta Investment Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 388 shares — an estimated $202K sold.

Realta Investment Advisors first reported a position in TMO in Q1 2019 and held it in 18 quarters. The position peaked at $666K in Q2 2019. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Realta Investment Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Realta Investment Advisors sold 388 Thermo Fisher Scientific shares in Q3 2023, an estimated $202K.
  • Realta Investment Advisors first reported a position in Thermo Fisher Scientific in Q1 2019 and held it in 18 quarters.
  • Realta Investment Advisors's Thermo Fisher Scientific position peaked at $666K in Q2 2019.
  • 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Realta Investment Advisors's 13F filing for Q3 2023, filed 20 Oct 2023.